Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
National Cancer Institute (NCI)
Royal Marsden NHS Foundation Trust
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
UNC Lineberger Comprehensive Cancer Center
Rigshospitalet, Denmark
Inhibrx Biosciences, Inc
University of Kentucky
Sanford Health
Dana-Farber Cancer Institute
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
University of Chicago
University of Alabama at Birmingham